BREAST-CANCER IS ASSOCIATED WITH LOSS OF THE C-KIT ONCOGENE PRODUCT

被引:107
作者
NATALI, PG
NICOTRA, MR
SURES, I
MOTTOLESE, M
BOTTI, C
ULLRICH, A
机构
[1] MAX PLANCK INST BIOCHEM, DEPT MOLEC BIOL, W-8033 MARTINSRIED, GERMANY
[2] CNR, INST BIOMED TECHNOL, ROME, ITALY
关键词
D O I
10.1002/ijc.2910520508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proto-oncogene c-kit encodes a tyrosine kinase receptor related to the PDGF/CSF-1 receptors. Mutations of this gene result in impairment of hematopoiesis, melanogenesis and gametogenesis. Using monoclonal antibodies to the c-kit gene product, we have analyzed its expression in normal and transformed human tissues. Unexpectedly, the receptor was found to be expressed in normal mammary epithelium. While in benign breast lesions, the c-kit gene product was detected at variable levels in 82% of the instances, in primary tumors, no product could be identified in 87% of the cases. This phenotype is maintained in metastatic foci. These findings were confirmed by paired Northern blot analysis of RNA preparations from normal and tumor tissues. These results demonstrate that the c-kit receptor may also be involved in the growth control of mammary epithelium and that this function may be impaired following malignant transformation and de-differentiation.
引用
收藏
页码:713 / 717
页数:5
相关论文
共 27 条
[11]   THE DOMINANT-WHITE SPOTTING (W) LOCUS OF THE MOUSE ENCODES THE C-KIT PROTO-ONCOGENE [J].
GEISSLER, EN ;
RYAN, MA ;
HOUSMAN, DE .
CELL, 1988, 55 (01) :185-192
[12]   THE HEMATOPOIETIC GROWTH FACTOR-KL IS ENCODED BY THE SI-LOCUS AND IS THE LIGAND OF THE C-KIT RECEPTOR, THE GENE-PRODUCT OF THE W-LOCUS [J].
HUANG, E ;
NOCKA, K ;
BEIER, DR ;
CHU, TY ;
BUCK, J ;
LAHM, HW ;
WELLNER, D ;
LEDER, P ;
BESMER, P .
CELL, 1990, 63 (01) :225-233
[13]  
KOSTER A, 1991, ANTICANCER RES, V11, P193
[14]   RNA MOLECULAR-WEIGHT DETERMINATIONS BY GEL-ELECTROPHORESIS UNDER DENATURING CONDITIONS, A CRITICAL RE-EXAMINATION [J].
LEHRACH, H ;
DIAMOND, D ;
WOZNEY, JM ;
BOEDTKER, H .
BIOCHEMISTRY, 1977, 16 (21) :4743-4751
[15]   HOW TO USE PROGNOSTIC FACTORS IN AXILLARY NODE-NEGATIVE BREAST-CANCER PATIENTS [J].
MCGUIRE, WL ;
TANDON, AK ;
ALLRED, DC ;
CHAMNESS, GC ;
CLARK, GM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (12) :1006-1015
[16]  
NATALI PG, 1992, 83RD P ACCR M S DIEG, V33, P22
[17]  
NATALI PG, 1992, IN PRESS INT J CANCE
[18]  
PARKIN DM, 1984, B WORLD HEALTH ORGAN, V62, P163, DOI 10.1139/b84-027
[19]  
PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
[20]  
RILKE F, 1982, TUMORI, V68, P181